Clinical Trials

What Does High-Dose Nusinersen Mean for SMA Treatment?
Research & Development What Does High-Dose Nusinersen Mean for SMA Treatment?

Spinal Muscular Atrophy (SMA), a rare genetic disorder that causes progressive muscle weakness and significant life challenges, has long been a focus of medical research seeking transformative solutions for affected individuals across all ages. A pivotal moment in this journey arrived on November

How Can We Improve Diagnosis of Radiation Brain Injury?
Tech & Innovation How Can We Improve Diagnosis of Radiation Brain Injury?

Diving into the complex world of radiation-induced brain injury (RIBI), we’re thrilled to speak with a leading expert in radiation oncology and neuroimaging. With years of experience in both clinical practice and cutting-edge research, our guest today has dedicated their career to understanding the

Can New Research Combat Drug-Resistant Fungal Infections?
Research & Development Can New Research Combat Drug-Resistant Fungal Infections?

In a world where medical advancements have conquered countless diseases, a silent yet deadly threat looms large—drug-resistant fungal infections are claiming millions of lives each year, often with little public attention. These infections strike hardest at the most vulnerable, such as cancer

Iambic Secures $100M for AI-Driven Cancer Drug Trials
Research & Development Iambic Secures $100M for AI-Driven Cancer Drug Trials

In a groundbreaking moment for the biotechnology sector, San Diego-based startup Iambic has captured the spotlight by raising an impressive $100 million in Series B financing to propel clinical trials of its AI-discovered cancer drugs, marking a significant milestone for the company. This

World's First Lung Cancer Vaccine Trial Begins in 2026
Research & Development World's First Lung Cancer Vaccine Trial Begins in 2026

In a monumental step forward for medical science, the announcement of the world’s first clinical trial for a lung cancer prevention vaccine, known as LungVax, marks a turning point in the battle against one of the deadliest diseases globally, with the trial slated to commence in 2026. Developed

How Does Brain Fluid Dynamics Impact Glioblastoma Survival?
Research & Development How Does Brain Fluid Dynamics Impact Glioblastoma Survival?

Glioblastoma, recognized as the most aggressive and common form of brain cancer, especially in its IDH wild-type variant, remains a daunting challenge with survival rates often limited to about a year despite intensive treatments like surgery, radiotherapy, and chemotherapy. A groundbreaking study

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later